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GABAA receptors (GABAA Rs) play a crucial role in inhibition in the central nervous
system. GABAA Rs containing the δ subunit mediate tonic inhibition, have distinctive
pharmacological properties and are associated with disorders of the nervous system.
To explore this receptor sub-class, we recently developed mice with δ-containing
receptors rendered resistant to the common non-competitive antagonist picrotoxin
(PTX). Resistance was achieved with a knock-in point mutation (T269Y; T6’Y) in
the mouse genome. Here we characterize pharmacological and biophysical features
of GABAA Rs containing the mutated subunit to contextualize results from the KI
mice. Recombinant receptors containing δ T6’Y plus WT α4 and WT β2 subunits
exhibited 3-fold lower EC50 values for GABA but not THIP. GABA EC50 values in
native receptors containing the mutated subunit were in the low micromolar range, in
contrast with some published results that have suggested nM sensitivity of recombinant
receptors. Rectification properties of δ-containing GABAA Rs were similar to γ2containing receptors. Receptors containing δ T6’Y had marginally weaker sensitivity
to positive allosteric modulators, likely a secondary consequence of differing GABA
sensitivity. Overexpression of δT6’Y in neurons resulted in robust PTX-insensitive IPSCs,
suggesting that δ-containing receptors are readily recruited by synaptically released
GABA. Overall, our results give context to the use of δ receptors with the T6’Y mutation
to explore the roles of δ-containing receptors in inhibition.
Keywords: GABA allosteric modulators, inhibition, antidepressant, dentate gyrus, neurosteroid, ethanol

INTRODUCTION
Activation of GABAA Rs inhibits targets expressing the receptors and sculpts patterns of the activity
responsible for thought, emotion, and in fact virtually all brain functions. Two major subclasses
of GABAA Rs are prominently expressed in the CNS, sometimes within the same cell type. γ2Containing receptors are typically found at synapses and mediate phasic inhibition caused by the
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synaptic release of GABA. In contrast, δ-containing receptors
are expressed in more circumscribed populations of neurons
and tend to mediate tonic currents to ambient GABA and
a slow component of IPSCs (Nusser et al., 1998; Wei
et al., 2003; Martenson et al., 2017; Sun et al., 2018, 2020).
δ-Containing receptors are also thought to have high sensitivity
to certain positive allosteric modulators, such as neurosteroids
and ethanol (Mihalek et al., 1999; Spigelman et al., 2003;
Stell et al., 2003; Wei et al., 2004; Glykys et al., 2007),
although our recent results questioned this selectivity (Lu
et al., 2020). Features of both GABAA R subclasses make them
attractive targets for therapeutics in different situations. A
more nuanced understanding of the properties of δ-containing
and γ2-containing receptors would aid the search for targeted
therapeutics and aid understanding of the specific roles of
different receptor sub-classes.
To aid the exploration of the two subclasses of GABAA Rs,
we recently introduced knock-in (KI) mouse lines that
carry pharmacoresistance to picrotoxin (PTX) as a means
of isolating the two receptor classes (Sun et al., 2018).
Studies of the KI mice revealed a greater contribution of δcontaining receptors to IPSCs of dentate granule cells (DGCs)
than expected (Sun et al., 2018, 2020). The KI mice also
revealed little or no preferential sensitivity to neurosteroids
(Lu et al., 2020). An open question is whether receptors
containing the mutant δ subunit are sufficiently different
pharmacologically from WT δ-containing receptors to explain
the unexpected results.
PTX-resistant GABAA R subunits were engineered and
partially characterized previously. It was found that the T6’Y
mutation could be made in any subunit of a pentameric GABAA R
to reduce or eliminate PTX sensitivity (Gurley et al., 1995;
Sedelnikova et al., 2006; Erkkila et al., 2008). In γ2 receptors,
this amino acid substitution had little effect on GABA EC50
(Erkkila et al., 2008), but when introduced into mice, γ2T6’Y
causes a seizure phenotype that appears to arise from slightly
altered kinetics of synaptic currents (Sun et al., 2019). The
comparable mutation in δ subunit-containing receptors has not
been characterized in as much detail, although we have shown
that kinetics and agonist sensitivity are similar to WT in native
DGCs (Sun et al., 2018, 2019).
Here we use a combination of recombinant receptor subunits,
where we can directly compare WT and mutated subunits,
and tissue slices, where subunits are expressed in a native
environment, to examine pharmacological and biophysical
properties of GABAA Rs that may be important to their
physiological role. We found that receptors with a mutated δ
subunit exhibit ∼3-fold higher sensitivity to GABA, leading to
marginally altered responsiveness to allosteric modulators. We
also found that mutant receptors exhibit similar rectification
to WT δ-containing receptors and γ2-containing receptors
in native cells. Thus, rectification is unlikely to increase the
prominence of δ-containing receptors relative to γ2-containing
receptors at transmembrane voltages positive to rest. Overall,
our results show that pharmacoresistant KI mice are valid tools
for evaluating the roles of GABAA R sub-classes if caveats are
considered.
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METHODS
Cell Culture and Recombinant Receptor
Expression
The murine neuroblastoma Neuro-2a (N2a; ATCC No. CCL131) cell line was grown in Dulbecco’s Modified Eagle’s medium
(DMEM) supplemented with 10% (v/v) FBS, 2 mM glutamine
plus 100 U/ml penicillin, and 0.1 mg/ml streptomycin in an
atmosphere of 5% CO2 and 95% air, and was maintained at
sub-confluent densities in the growth media.
GABAA Rs were expressed in N2a cells by transiently
transfecting the cDNAs of free α4, β2, and δ subunits of
the GABAA R. The cDNA for human α4 was obtained from
Dr. Paul Whiting (Merck, Harlow, Essex, UK), rat β2 was
obtained from Dr. David Weiss (University of Texas Health
Science Center, San Antonio, TX, USA), and rat δ was provided
by Dr. Robert Macdonald (Vanderbilt University, Nashville,
TN, USA). The δ(T269Y; δT6’Y) mutation was used to confer
resistance to PTX (Gurley et al., 1995). The mutations were made
using the QuikChange site-directed mutagenesis kit (Agilent
Technologies, Santa Clara, CA). The δ subunit contained the
FLAG epitope in the amino terminus of the subunit (Ueno et al.,
1996). Transfection was carried out using a total of 1.2 µg of
cDNA in the ratio of 1:1:2(α:β:δ), along with reporter plasmid
(GFP, Clontech Laboratories, Mountain View, CA) as a positive
transfection marker. Lipofectamine2000 (Life Technologies,
Carlsbad, CA) was used as a transfection reagent according to the
manufacture’s protocol. Electrophysiological experiments were
performed 48–72 h later following transfection.
Rat primary cultures of hippocampal cells were prepared
from 1 to 3 day postnatal Sprague Dawley rats, as described
previously (Mennerick et al., 1995). Tissue was prepared
according to protocols approved by the Institutional Animal
Care and Use Committee. The GABAA R subunits were
transduced with AAV8-Syn-α4-IRES-GFP, AAV8-Syn-δT6’YIRES-GFP, and AAV8-Syn-GFP virus 5 days after plating (Syn
refers to the human synapsin promoter). Viral preparation was
supported by the Hope Center Viral Vectors Core at Washington
University School of Medicine. Electrophysiological experiments
were performed 7 days following viral infection.

Whole-Cell Patch-Clamp Recording in Cell
Cultures
Experiments on N2a cells were conducted using standard
whole-cell techniques. Non-transfected cells had no response to
GABA. The bath solution containing (in mM): 138 NaCl, 4 KCl,
2 CaCl2 , 1 MgCl2 , 10 glucose, and 10 HEPES; pH 7.25. Patch
pipettes were filled with an internal solution containing (in mM):
130 CsCl, 4 NaCl, 4 MgCl2 , 0.5 CaCl2 , 5 EGTA, 10 HEPES, pH
7.25. When filled with this solution, pipette tip resistance was
3–6 MΩ. Cells were clamped at −70 mV. Drugs and elevated
potassium were applied with a multibarrel, gravity-driven local
perfusion system. The estimated solution exchange times were
10–20 ms, measured by the change in junction currents at the tip
of an open patch pipette. A typical drug application consisted of
recording 2 s of baseline, followed by a 4–8 s drug application
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to block non δ-containing receptors in δT6’Y CRISPR KI slices,
and the holding current was recorded throughout.
To measure the GABA sensitivity of δ-containing receptors,
nucleated patches were obtained (Sather et al., 1992) to minimize
the influence of GABA uptake on GABA responses. After PTX
application, GABA at 1, 10, and 30 µM was applied. Data were
plotted in Prism (Graphpad, San Diego, CA).
To measure subunit contributions to tonic current and to
measure rectification of GABAA R-mediated current, DGCs from
WT, δT6’Y KI, or γ2T6’Y KI slices were recorded at −70 mV.
Exogenous GABA (5 µM) was applied to induce a basal tonic
current, followed by PTX co-application (50 µM) to separate δcontaining receptors from γ2-containing receptors in the two
KI lines. The competitive GABAA R antagonist gabazine (GBZ,
50 µM) was applied to block the remaining GABAA Rs at the end
of recordings. Current remaining after the GBZ application was
taken as a 0-level tonic current. For rectification, the currentvoltage (I-V) relationship of tonic currents mediated by δcontaining receptors or γ2-containing receptors was measured
by applying a slow (10 s) voltage ramp from −100 mV to 60 mV
in the presence of Cd2+ to block voltage-gated Ca2+ channels.
Rectification index (RI) represents the ratio of conductance of
GABAA Rs at −60 mV and +60 mV and was calculated as follows:
RI = [I +60 /(60 − Erev )]/[I −60 /(−60 − Erev )].

and a bath application (up to 1 min) until full recovery. Culture
recordings were performed at room temperature.
Currents were filtered at 2 kHz and recorded at 5 kHz with an
Axopatch 200 B amplifier (Molecular Devices, San Jose, CA). The
analysis of current traces aimed at determining the peak current
was conducted using pClamp 9.0 software (Molecular Devices).
All recordings were performed at room temperature. Charge
calculations for phasic currents were performed in Clampfit with
cursors set at the onset and of K+ application and using the
built-in statistics functions of Clampfit to calculate the integral
of current over time.
EC50 values for GABA and THIP were derived from fits to
the Hill equation with the Hill coefficient constrained to ≤3 for
both GABA and THIP to account for multiple binding sites.
Comparisons of the sensitivity to agonist were made by the Extra
sum-of-squares F test implemented in GraphPad Prism software
with a p criterion of 0.05. Alternatively, individual cells were fit
by the Hill equation, followed by a one-way ANOVA and Sidak’s
multiple comparisons test if the ANOVA revealed a difference.
For the latter approach, THIP data from 4 WT cells and 5 cells in
the δT6’Y conditions were excluded due to non-converging fits
or outlier EC50 values (>5 standard deviations beyond mean).

Slice Preparation
Mice from WT, δT6’Y KI, and γ2T6’Y KI of either sex were
used for experiments at postnatal day (P) 30 ± 2 days (Sun
et al., 2018). Coronal brain slices at 300-µm thickness were
cut in ice-cold, modified artificial CSF (aCSF containing in
mM: 87 NaCl, 75 sucrose, 25 glucose, 25 NaHCO3 , 2.5 KCl,
1.25 NaH2 PO4 , equilibrated with 95% oxygen-5% CO2 plus
0.5 CaCl2 , 3 MgCl2 ; 320 mOsm). Slices were incubated in
choline-based recovery aCSF (in mM: 92 choline chloride,
25 glucose, 30 NaHCO3 , 2.5 KCl, 1.2 NaH2PO4 , 20 HEPES,
2 thiourea, 5 Na ascorbate, 3 Na pyruvate, 2 CaCl2 , and 1 MgCl2 ,
oxygenated; 300 mOsm) at 32◦ C for 30 min, and then stored in
regular aCSF (in mM: 125 NaCl, 25 glucose, 25 NaHCO3 , 2.5 KCl,
1.25 NaH2PO4 , oxygenated; 310 mOsm) for at least 1 h at 25◦ C
before experimental recording. To measure GABAA R activation,
10 µM NBQX and 50 µM D-APV were added in the regular aCSF
to inhibit ionotropic glutamate receptors.

Drugs
GABA, pentobarbital, and salts were purchased from SigmaAldrich (St. Louis, MO). DS2 [4-chloro-N-2-(2-thienyl)
imidazo[1,2-a]pyridine-3-yl benzamide] was purchased from
R&D Systems (Minneapolis, MN). Steroids were from SigmaAldrich, or Steraloids (Newport, RI). Channel blockers NBQX
and D-APV were from Tocris Bioscience (Minneapolis, MN).

RESULTS
Agonist Sensitivity in Recombinant
GABAA Rs and CRISPR Mutation Knock-In
Mice
To characterize pharmacological and biophysical features of
GABAA Rs containing the δT6’Y subunit, we first examined
activation by the natural agonist GABA. Figure 1A shows a
typical response elicited by 1 µM of GABA from wild type (WT)
α4β2δ subunits transfected into N2a cells. The response was
strongly inhibited when co-applied with the channel blocking
antagonist PTX at 100 µM. PTX sensitivity was absent when
δT6’Y was introduced with WT α4 and β2 subunits, but
the activation by GABA was retained. Overall, there was no
difference in the amplitude of GABA responses to 1 µM GABA
in the presence or absence of 50 µM PTX (−129.7 ± 21.5 pA
vs. −138.4 ± 22.2 pA, n = 27, 26; p = 0.78, t-test). We note that
incorporation of δ subunits into recombinant receptors has been
controversial, and PTX insensitivity of δT6’Y (or the comparable
mutation in other subunits) yields a useful marker of subunit
incorporation.
To further understand the impact of this mutation on the
function of GABAA Rs, we investigated a full concentration-

Slice Whole-Cell Recording
Brain slices were transferred into a recording chamber with
oxygenated, regular aCSF perfused at 2 ml/min at 32◦ C.
Hippocampal DGCs were identified by IR-DIC microscopy
(Nikon FN1 microscope and Photometrics Prime camera).
Whole-cell recordings were performed with pipettes pulled
from borosilicate glass and with open tip resistance of
3–7 MΩ. Pipettes contained the following in mM: 130 CsCl,
10 HEPES, 5 EGTA, 2 MgATP, 0.5 NAGTP, and 4 QX314; pH adjusted to 7.3 with CsOH; 290 (mOsm). Recordings
began 5 min after whole-cell configuration was established.
Signals were recorded using a MultiClamp 700B amplifier
(Molecular Devices), Digidata 1550 16-bit A/D converter, and
pClamp 10.4 software (Molecular Devices). To measure (4,5,6,7tetrahydroisoxazolo[5,4-c]pyridin-3-ol) THIP currents, DGCs
were voltage-clamped at −70 mV, and PTX (50 µM) was applied
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FIGURE 1 | Continued
the residual holding current in the presence of GBZ. (I) Percentage of tonic
current mediated by δ-containing receptors (n = 7, 19.6% ±2.9%). (J–L) The
same experiment from γ2T6’Y KI DGCs. Similar to δT6’Y KI DGCs, PTX
partially blocked the GABA-induced tonic currents (n = 7, paired t-test,
−63.2 ± 21.0 vs. −27.2 ± 7.9 pA, p = 0.0383). The contribution of
γ2-containing receptors was calculated (n = 7, 45.4% ± 7.6), with the
balance (∼55%) mediated by non-γ2 containing receptors. PTX, picrotoxin;
KI, knock-in; DGCs, dentate granule cells.

response relationship by varying GABA concentration in WT
and δT6’Y receptors (Figures 1B,C). We observed that the EC50
of receptors containing the δ T6’Y mutation was left-shifted
when compared to WT δ-containing receptors (1.33 µM and
3.61 µM, respectively, p < 0.001, Extra Sum of Squares F test).
Alternatively, comparison of EC50 values by fits to data from
individual cells by one-way ANOVA (see ‘‘Methods’’ section)
showed similar results: overall effect on EC50 (F (2, 21) = 21.77;
p < 0.001), with post hoc comparison revealing a difference
between genotypes (adjusted p-value < 0.0001) but not between
PTX conditions in the δT6’Y cells. However, we failed to detect
a lower EC50 for the δ-preferring agonist THIP (Figure 1C
lower panel 38.7 µM and 16.7 µM for WT and δ T6’Y mutated
group, respectively; p = 0.06, Extra Sum of Squares F test).
Individual fits for THIP revealed a similar result: (one-way
ANOVA F (2, 29) = 2.596, p = 0.092)
In addition, we performed GABA and THIP concentrationresponse experiments on receptors bearing the δT6’Y mutation
in the presence of 50 µM PTX (Figure 1C, blue symbols). The
EC50 for GABA but not THIP was detectably altered by the
δT6’Y mutation, and PTX presence did not alter the EC50 on
the mutated receptors (Figure 1). These values were very similar
to those in the absence of PTX, further highlighting the lack of
significant PTX effect on mutant receptor function.
The finding of reduced agonist EC50 values in recombinant
GABAA Rs for the natural agonist GABA leads to the question
of how agonists behave on δ GABAA Rs in native cells, especially
since WT recombinant δ-containing receptors exhibit a range of
estimated EC50 values, from low nM to high µM (Brown et al.,
2002; Karim et al., 2012, 2013; Eaton et al., 2014; Wongsamitkul
et al., 2016). Although we could not evaluate WT native δ
GABAA Rs because of the lack of selective pharmacology, we
evaluated δ-containing GABAA Rs using PTX-resistant δT6’Y KI
DGCs, a cell type rich in δ-containing receptors. We performed
nucleated patch recordings, lifted from the slice, to avoid the
complication of GABA uptake, which lowers the local GABA
concentration in tissue to indeterminant values (Isaacson et al.,
1993). In the presence of PTX, exogenous GABA increased
current in nucleated patches from 1 µM to 30 µM and recovered
after GABA wash off (Figures 1D,E). The results suggest that
the increased sensitivity to GABA evident in recombinant
GABAA Rs is not readily evident in native cells. To examine
receptor sensitivity using a method that doesn’t suffer from
the disadvantages of patch excision and for which recombinant
receptors did not exhibit clear alteration in sensitivity, we
examined whole-cell current activated by the poorly transported
δ-preferring agonist THIP. Similar to GABA application, the

FIGURE 1 | Agonist sensitivity in recombinant α4β2δ GABAA Rs expressed in
N2a cells and KI mice. (A) Example traces of response to 1 µM GABA elicited
from N2a cells transfected with wildtype (WT) GABAA R subunits. This
response was abolished by co-application of 100 µM PTX. The δT6’Y
mutation exhibited PTX-insensitivity when expressed with α4 and β2 subunits.
(B) Representative traces of different GABA concentrations (0.3–30 µM) from
WT GABAA Rs and δT6’Y mutation expressed in N2a cells. Shading indicates
different GABA concentrations. (C) Concentration response curves for
agonists GABA and THIP, respectively. For GABA, fits to the Hill equation
yielded EC50 values of 3.61 µM, 1.33 µM, and 1.21 µM for WT and δT6’Y
and δT6’Y in the presence of 50 µM PTX, respectively. The Hill coefficients
were 1.1, 1.3, and 1.3 respectively. The EC50 values for WT and δT6’Y
differed as assessed by the sum of squares F test (p < 0.0001). The sum of
squares as a measure of goodness of fit was 0.386, 0.179, and
0.141 respectively for WT, δT6’Y, and δT6’Y + PTX. For THIP, fits to the Hill
equation yielded EC50 values of 38 µM, 17 µM, and 31 µM for WT, δT6’Y,
and δT6’Y + PTX, respectively with Hill coefficients of 0.79, 1.14, and 0.94.
The p-value for a sum-of-squares F test on EC50 values of WT vs. δT6’Y was
0.061. The sum of squares as a measure of goodness of fit was 0.004,
0.010, 0.0007. (D–F) Slice recording from DGCs of δT6’Y KI mice showing
agonist sensitivity of δ-containing GABAA Rs. All traces were obtained in the
presence of 50 µM PTX. (D) Example traces of holding current after perfusing
different concentrations of GABA. (E) Summary of current induced by
different concentrations of GABA in nucleated patch-clamp recording (gray
lines represent individual patches). (F) Summary of current induced by
different concentrations of THIP in whole-cell recordings. (G) Representative
whole-cell recording from δT6’Y KI DGC. Exogenous GABA (5 µM) induced a
tonic current partially blocked by PTX (50 µM). Gabazine (GBZ) completely
abolished the tonic current. (H) Summary of tonic currents mediated by
δ-containing receptors and all GABAA R (n = 7, paired t-test, −63.6 ± 13.2 pA
vs. −11.8 ± 2.2 pA, p = 0.0037). Both measurements are subtracted from
(Continued)
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current mediated by δ-containing receptors increased as THIP
concentration increased from 1 µM to 30 µM (Figure 1F). These
results show that in DGCs the EC50 for both natural and δpreferring agonists is in the micromolar range rather than in the
nM range as has been observed in some recombinant receptor
experiments.
Given that the response of δT6’Y-containing receptors in
native cells does not appear to exhibit the higher sensitivity
to GABA observed in recombinant receptors, we evaluated the
contribution of δ-containing receptors to GABA-induced tonic
current using both δT6’Y and γ2T6’Y knock-in mouse lines (Sun
et al., 2018; Lu et al., 2020). In mouse hippocampal DGCs, we
induced tonic current with 5 µM GABA, typical of previous
work (Lee and Maguire, 2014). In both δT6’Y KI and γ2T6’Y KI
DGCs, 5 µM GABA induced ∼60 pA tonic current. This current
was partially blocked by 50 µM PTX, leaving PTX-resistant
tonic current. GBZ (50 µM) was applied to eliminate
the remaining tonic current (Figures 1G,J). Surprisingly, δcontaining receptors mediated ∼20% of the GABA-induced
tonic current (Figures 1H,I), judged by PTX-resistant current
in δT6’Y KI cells. By contrast, non-γ2 containing receptors
mediated 55% of the tonic current from the γ2T6’Y cells
(Figures 1K,I). Both mouse lines indicate a smaller contribution
of δ-containing receptors to GABA-induced tonic current than
previous work has suggested. Possible reasons for the discrepancy
in estimates for δ contribution within the two KI mouse lines are
evaluated in the Discussion.

allosteric modulator (PAM; Jensen et al., 2013); and ethanol.
Figure 3 shows that pentobarbital (50 µM), AlloP (50 nM),
and DS2 (1 µM) all potentiated responses to 1 µM GABA
in both WT and δT6’Y receptors (Figures 3A,B). A two-way
ANOVA applied to data in Figure 2B revealed that overall, δT6’Y
exhibited less potentiation from modulators (F (2, 145) = 10.04,
p < 0.001. However, post hoc comparisons showed only marginal
differences for each modulator (Figure 3B). Ethanol modestly
potentiated both WT and δT6’Y currents at 30–100 mM
(Figure 3C; 100 mM shown). We attribute the overall reduced
sensitivity of δT6’Y receptors to positive modulators to be the
likely secondary consequence of reduced agonist EC50 (Figure 1).
Overall, we conclude that positive allosteric modulators act
similarly in WT and δT6’Y-containing receptors.

DS2-Sensitive PTX-Insensitive Responses
in Rat Hippocampal Cultures
Hippocampal neurons prominently express γ2-containing
GABAA Rs that traffic mainly to synapses, while δ-containing
receptors are located perisynaptically or extrasynaptically,
mainly in DGCs in the hippocampus (Wei et al., 2003). Because
δ-containing receptors are thought to mediate mainly tonic
GABA currents, we tested whether δ receptors are excluded
from activation by synaptic GABA release. We used viral
transduction of δT6’Y along with the preferred δ partner α4 in
hippocampal neurons. GFP + α4 and non-transduced cells were
used as controls. First, we evaluated the functional expression of
transduced subunits. We used PTX resistance and sensitivity to
the δ-preferring PAM DS2 to implicate δ-containing receptors.
Figures 4A,B shows representative responses to 0.2 µM
GABA ± 1 µM DS2 in the presence of PTX in control and
δT6’Y neurons. WT cells demonstrated that there was little
‘‘breakthrough’’ GABA current in the presence of PTX. These
examples and summary data in Figure 4C in the absence of
PTX suggest that control cultures have almost no endogenous
δ in functional receptors, probably owing to the prominence
of pyramidal neurons rather than granule neurons in the
cultures. δT6’Y alone (without α4) was also capable of sustaining
responses to GABA and DS2, suggesting that δT6’Y can partner
with endogenous α and β subunits to form functional receptors
(Figure 4C).

Rectification Does Not Differ Among
Native GABAA R Isoforms
We extended the examination of native receptors in DGCs to
rectification properties. GABAA R-mediated tonic current shows
strong outward rectification in CA1 pyramidal cells (Pavlov et al.,
2009). Outward rectification of conductance in the range of
voltages from −70 mV to near action potential threshold will
influence excitability, and disproportionate outward rectification
of GABA current mediated by δ-containing receptors could
perhaps help explain the small contribution of these receptors
in our experiments compared with previous work (Stell et al.,
2003; Wei et al., 2003). To examine whether outward rectification
is stronger in δ-containing GABAA Rs than in γ2-containing
receptors, we measured the tonic current of DGCs while
applying a slow voltage ramp from −100 mV to +60 mV
(Figures 2A–E). After applying sequential PTX and GBZ in
slices from PTX-resistant δT6’Y KI and γ2T6’Y KI mice, we
calculated the rectification index of GABA current mediated
by δ-containing receptors and by γ2-containing receptors,
respectively (Figures 2A–E). Our results suggest that rectification
is similar among the three genotypes (Figures 2B,D,F).

Synaptic Activation of Overexpression of
δT6’Y Mutation in Rat Hippocampal
Cultures
Given the robust expression of δT6’Y in hippocampal cultures
(Figure 4), we explored whether δ receptors are accessed by the
synaptic release of GABA. We recorded from infected cells while
challenging the surrounding network with 6 mM potassium
in the presence of PTX and the glutamate receptor blockers
NBQX and D-APV. The currents in Figure 5A thus represent
PTX-insensitive IPSCs from the recorded cell. The contribution
of δ receptors was verified with DS2 (1 µM) application, which
prolonged IPSCs (Figures 5A,E). IPSCs were also sensitive
to GBZ, a competitive GABAA R antagonist (Figure 5A3). In
control GFP-only cells (also recorded in the presence of receptor
antagonists), potassium-elicited currents were much smaller

Positive Allosteric Modulator (PAM)
Sensitivity in Recombinant Receptors
Many important experimental and clinically used compounds
augment GABAA R function. Do these compounds act as
expected at receptors containing the δT6’Y mutation? We
tested pentobarbital, a barbiturate; allopregnanolone (AlloP), an
endogenous neurosteroid; DS2, a δ-receptor preferring positive
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FIGURE 2 | Rectification does not differ among GABAA R isoforms in slice recording. (A) In a representative WT DGC, GABAA R-mediated tonic current shows
outward rectification. (B) Summary of GABAA R rectification index (RI). PTX and GBZ show similar blockage of GABAA R-mediated tonic current in WT DGCs (n = 7,
paired-t test, 3.1 ± 0.4 vs. 3.3 ± 0.7, p = 0.8275). (C,D) Tonic current mediated by δ-containing GABAA Rs shows outward rectification. Note that RI of total
GABAA Rs, non δ-containing GABAA Rs, and δ-containing GABAA Rs are shown as GABA-GBZ, GABA-PTX, and PTX-GBZ, respectively. One-way ANOVA showed
no drug effect on RI (F (1.195, 6.575) = 0.1512, p = 0.7532). (E,F) Tonic current mediated by γ2-containing GABAA Rs shows outward rectification. One-way ANOVA
showed no drug effect on RI (F (1.587, 4.762) = 0.1155, p = 0.8518). RI values in the various conditions were obtained from antagonist subtractions as indicated below
the graphs in (B,D,F).

The primary change in receptor function is a reduction in
GABA EC50 in recombinant GABAA Rs, which may also account
for the reduced sensitivity of receptors to positive allosteric
modulators at a fixed agonist concentration. EC50 differences
could arise from genuine changes in the binding properties of the
receptor or from changes to the gating properties of the receptor
(Colquhoun, 1998). Given that the amino acid substitution
occurs within TM2, near important pore-forming residues, it
seems likely that gating properties are primarily affected and
agonist binding affected indirectly.
A puzzling attribute of the mutant receptors is the altered
EC50 for GABA but not for THIP (Figure 1). Although
speculative, a possible reason for the difference is the partial
agonist quality of GABA compared with the full agonist
properties of THIP at δ subunit-containing receptors (Brown
et al., 2002). The mutation may affect the EC50 for partial
agonists but not for full agonists, because of different receptor
conformations adopted by bound full vs. partial agonists.

(Figures 5B,D), reflecting primarily direct potassium effects, and
were insensitive to DS2 and to GBZ (Figures 5B1–B3,E). To test
that phasic events were indeed synaptically driven, we confirmed
that lowering bath Ca2+ eliminated the phasic events in each
of the 10 cells tested (Figure 5C). We conclude that δ subunitcontaining receptors are readily activated by synaptically released
GABA, at least under conditions of exogenous transduction.
Note that our experiments do not determine whether the
activated receptors are anatomically synaptic, perisynaptic, or
extrasynaptic.

DISCUSSION
We have evaluated the effect on the receptor function of a point
mutation in the δ subunit of GABAA Rs expressed heterologously
and as a knock-in in DGCs. The point mutation has the intended
effect on PTX sensitivity. However, the results also show that
the mutation is not completely silent in the absence of PTX.
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FIGURE 3 | PAM sensitivity in recombinant α4β2δ GABAA Rs expressed in N2a cells. (A) Example traces of response elicited from GABA (1 µM) potentiated by
pentobarbital (25 µM) and AlloP (50 nM) in WT GABAA Rs, δT6’Y GABAA Rs as indicated. (B) Summary of pentobarbital, AlloP and, DS2 effects on GABA current with
10 s application time (n = 12–19) in WT δ and δT6’Y containing receptors. Note that δT6’Y in the presence of 50 µM PTX is also represented. A two-way ANOVA
showed a main effect of genotype (F (2, 145) = 10.04, p < 0.0001), with p-values for post hoc Sidak’s multiple comparison test given above the graphs. (C) Ethanol
sensitivity was evident as a slight increase above baseline in WT or δT6’Y GABAA Rs (two-way ANOVA (F (1, 36) = 4.497; p = 0.04, n = 19 per group). However, no
genotype or genotype by ethanol interaction was evident (interaction: F (1, 36) = 0.038; p = 0.85). PAM, Positive Allosteric Modulator.

view that δ receptors solely mediate tonic current. Previously,
using PTX-resistant γ2 knock-ins, we used PTX isolation and
digital subtraction to isolate WT δ IPSCs in DGCs and failed to
discern a difference in amplitude or decay kinetics of δ mediated
IPSCs, between WT and δT6’Y IPSCs (Sun et al., 2018, 2020),
based on the assumption that δ receptors in γ2T6’Y mice retain
WT features. Therefore, it appears that the mutation has a limited
functional impact on DGCs. The possible reasons are considered
below.
The lower EC50 to GABA of δT6’Y receptors predicts a
larger tonic current in T6’Y DGCs in response to a fixed, low
GABA concentration, but this prediction was not borne out.
We also previously showed that responses to a sub-saturating
concentration of the δ-preferring agonist THIP were not
discernibly different from those of WT receptors in DGCs (Sun
et al., 2018; Lu et al., 2020). If tonic GABA responses were
augmented because of the lower agonist EC50 in T6’Y receptors,

We previously used δT6’Y mice, also employed in the current
study, along with γ2T6’Y knock-in mice to argue that δ receptors
contribute more to synaptic IPSCs in DGCs than prevailing views
typically suggest (Sun et al., 2018, 2020). Our present experiments
reinforce these observations with an acute expression of δ
subunits in primary cultures (Figures 4, 5). Several pieces of
evidence suggest that the phasic events are of synaptic (vesicular)
origin rather than from reverse GABA uptake. First, the events
are Ca2+ dependent (Figure 5C). Although interactions between
synaptic glutamate release and reverse GABA transport are
formally possible (Guimarães-Souza et al., 2011), reverse GABA
transport is evoked by stronger depolarization and with a slower
time course than in our experiments (Gaspary et al., 1998; Allen
et al., 2004). Note that neither our previous experiments nor the
present experiments speak to the anatomical location of the δ
containing receptors. Rather, the results suggest that δ receptors
can be accessed by synaptic GABA release and contradict the
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FIGURE 4 | Viral overexpression of δT6’Y mutation, along with WT α4 subunit, yields DS2-sensitive, PTX-insensitive GABA current in rat hippocampal cultures. All
data were collected in the presence of 50 µM PTX except for the far pair of bars in panel (C). (A,B) Representative responses to 0.2 µM GABA from a neuron
transduced with α4 subunit and from a neuron transduced with both α4 and δT6’Y virus as indicated. The α4 virus alone condition demonstrates that there is no
breakthrough GABA current in the presence of PTX. DS2 (1 µM) enhanced the GABA response in δT6’Y-containing receptors, indicating functional δT6’Y expression.
(C) Summary of GABA currents following indicated viral transduction. Colors illustrate GABA (in black) application and co-application with 1 µM DS2 (in red). The
weak DS2 effect in non-transduced cultures without PTX indicates low δ expression at baseline. ∗∗ p < 0.01, ∗∗∗ p < 0.001.

we may have overestimated δ contribution, exacerbating the
contrast with prevailing views. Here we also examined a range
of agonist concentrations in δT6’Y KI cells to test a hypothesis
of exceptionally high-affinity delta receptors (Karim et al.,
2012; Eaton et al., 2014). Our study constitutes the first direct
assessment of GABA sensitivity of δ receptors in native cells
and suggests that the EC50 of DGC δ receptors is in the
micromolar range, even with a possible three-fold lowering
induced by mutation. Thus, at least in DGCs, GABA and THIP
are not particularly high-potency agonists at native δ receptors.
Although the EC50 values differ from some published values
(Karim et al., 2012; Eaton et al., 2014; Pan et al., 2018), our
observations are in line with others (You and Dunn, 2007;
Mortensen et al., 2010). Our results in fact appear consistent
with a particular subunit arrangement in oocytes, forced by
concatemerized subunits (Eaton et al., 2014).
Our results show that δ-containing receptors mediate ∼20%
of GABAA R tonic current in δT6’Y KI DGCs, while in γ2T6’Y
KI DGCs, non γ2-containing receptors mediate ∼55% of the
tonic current. Although both are lower than previous estimates,
a possible reason for the internal discrepancy is that nonγ2 receptors besides δ receptors (e.g., γ1-containing receptors
and αβ-containing receptors) contribute to PTX-sensitive
current in γ2T6’Y cells (Mortensen and Smart, 2006). The
lower estimate of contribution from δ receptors in δT6’Y cells
suggests that high agonist affinity of δT6’Y (Figure 1C) does not
dominate, consistent with direct studies of GABA EC50 in DGCs
in Figures 1D,E. Poor functional expression of δT6’Y receptors
might explain the low δ contribution to GABA tonic current
in δT6’Y cells, but previously we presented multiple lines of
evidence that δT6’Y expression is near that of WT in DGCs (Sun
et al., 2018). Further, in our current work the total GBZ-sensitive
GABA current amplitude in the two mouse lines did not differ
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(Figures 1H,K). Thus, the evidence seems to favor non-γ2/nonδ receptor contributions to the tonic current to explain the
discrepancy in Figure 1I vs. Figure 1L.
Positive allosteric modulator sensitivity is important since
many drugs of this class are in clinical use or in clinical
development. Subunit selective modulators could represent
a new generation of therapeutics (Rudolph and Möhler,
2006, 2014). For instance, neurosteroids may have persistent
antidepressant effects by virtue of selectivity for δ receptors
(Maguire and Mody, 2008; Melón et al., 2018; Meltzer-Brody
and Kanes, 2020). On the other hand, our recent studies
suggested that δ receptors in the presence or absence of GABA
or THIP seem to exhibit little if any neurosteroid selectivity
over γ2 receptors (Lu et al., 2020). Here we found that
recombinant δT6’Y receptors retained sensitivity to allosteric
modulators, including AlloP and ethanol, with both WT and
δT6’Y receptors exhibiting very limited sensitivity to ethanol
in our hands. This finding differs from some previous results
(Wallner et al., 2006) but not others (Borghese et al., 2006).
Although an analysis of variance showed an effect of the
δT6’Y mutation on positive allosteric modulation, post hoc
analyses of individual PAMs indicated this global effect was
largely accounted for by reduced efficacy of PTB (Figure 3).
Because very different classes of compounds were used in these
experiments and no one compound accounted entirely for
the reduced overall effect (Figure 3), we hypothesize that the
change in agonist sensitivity ultimately underlies the difference
in the effects of modulators at a fixed agonist concentration.
The increased effectiveness of a fixed agonist concentration at
mutated receptors yields a smaller dynamic range for PAMs.
In our previous studies, this effect could have caused us to
underestimate AlloP potentiation in native cells bearing the
δT6’Y mutation. However, complementary results in native cells
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There are several reasons that differences in agonist sensitivity
observed in recombinant receptors might not be evident in
DGC native receptors. We cannot completely exclude the
possibility that native cells exhibit the same three-fold higher
sensitivity for GABA observed in recombinant receptors;
experiments in native cells embedded in tissue slices may
lack the precision obtainable in cultures, where exposure
to solution and drug is highly controlled. On the other
hand, there are potential reasons that a change observed in
recombinant receptors expressed in heterologous cells may not
be evident in native receptors. One possibility is that the beta
subunit differs in our recombinant receptors vs. native cells,
which could alter channel behavior. Another possibility is that
post-translational modification or interacting proteins differ
in the two environments. Regardless, the caveat of agonist
potency will be important to bear in mind when studying other
cell types.
GABAA Rs have voltage sensitivity that has been previously
suggested to contribute to inhibition by tonic current (Weiss,
1988; Pavlov et al., 2009). However, to our knowledge
rectification has been examined in recombinant δ GABAA Rs
(Brown et al., 2002) but not native δ-containing GABAA Rs.
We used δT6’Y to explore the hypothesis that δ receptors may
exhibit more rectification than γ2 receptors, giving rise to a more
prominent δ receptor contribution to tonic inhibition than our
previous results at a fixed membrane potential have suggested.
In contrast to the possibility of disproportionate δ receptor
rectification, we found no difference in rectification properties
among receptor subclasses in DGCs, so stronger rectification is
unlikely to contribute to a more prominent role of δ receptors in
inhibition.
In summary, our results suggest that δT6’Y is a helpful tool
for exploring the role of GABAA R subpopulations in neuronal
physiology and pharmacology. Caveats related to altered agonist
sensitivity have not been detectable in KI mice. Differences
detected in recombinant receptors need to be considered when
interpreting data from knock-in mice. However, with regard to
previous results with DGCs, we see no reason for conclusions
drawn to date to be revised. If the changes to baseline function are
detected in other native cell types, the present results may help to
circumvent the limitations.

FIGURE 5 | Synaptic activation of transduced δT6’Y subunits in rat
hippocampal cultures. (A1–3) Example traces of IPSCs induced by 6 mM K+
depolarizing stimulation after transduction of δT6’Y subunits along with
α4 subunits (A1). NBQX and D-APV were used to block AMPAR and NMDAR
activation, respectively, and 50 µM PTX was applied throughout. The K+
evoked IPSCs were enhanced by co-application with 1 µM DS2 (A2), and
sensitive to 10 µM gabazine (A3). The frequency of IPSCs may be reduced in
(A2) due to enhanced network inhibition with DS2 application. Residual
transient inward currents may represent small breakthrough IPSCs or small
action currents elicited by K+ depolarization in poorly clamped dendrites.
(B1–3) The same protocol was applied to neurons transfected with GFP
alone. The current initiated by 6 mM K+ was smaller, and DS2 enhancement
was absent. (C1,2) In the presence of PTX, NBQX, and D-APV, phasic events
in a δT6’Y + WT α4 transduced neuron were blocked by reduced Ca2+
(n = 10/10 cells), consistent with the synaptic release of GABA driving
postsynaptic responses. Upon reduction of extracellular Ca2+ to 0.1 mM in
panel (C2), extracellular Mg2+ concentration was increased to 3 mM to
preserve total divalent cation concentration. (D) Quantification of
PTX-insensitive synaptic charge for δT6’Y and control transfections (n = 8, 7,
unpaired t-test with Welch’s correction, p = 0.006). The charge was
integrated over the duration of K+ application, and charge in the presence of
GBZ was subtracted for the plots. (E) Summary of decay time constant τ
(ms) of the final IPSC of the barrage caused by K+ application.
DS2 significantly prolonged the decay of synaptic currents, indicating δ
contribution to the α4 + δT6’Y group but not the GFP control cells (n = 8, 7;
2-way ANOVA with Sidak’s multiple comparison test P < 0.0001 for α4 +
δT6’Y). The additional variability in (D) for the GFP control data likely arises
from the fits to small-amplitude currents [e.g., (B1) and (B2) vs. (A1) and
(A2)]. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ns = not significant.
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